Life Sciences and Medical Technologies
The Life Sciences industry in the midst of an unprecedented period of discovery and innovation in basic science, human disease, therapeutics, and patient care. Early successes in cell and gene therapy, precision medicine, and bioprocessing have catalyzed staggering amounts of capital investment in both clinical applications and the manufacturing technologies that enable them.
With over 50 transactions in Life Sciences and Healthcare, EC M&A is a leading M&A advisor in this market.
EC M&A is a member of the Alliance for Regenerative Medicine.
We cover the following subsectors:
Bioprocessing
Life Science Research Tools
Medical Devices & Diagnostics
Analytical Instruments
Pharmaceutical Production
Our Life Sciences Transactions
Please select using the filter and click the tombstone for details
View by Market Sector
Filter Categories
Life Sciences & Medical Technologies
All Life Sciences & Medical Technologies
Bioprocessing
Analytical Instruments
Life Science Research Tools
Medical Devices and Technology
Pharmaceutical Production
Filter Categories
Industrial Technologies
All Industrial Technologies
Energy (Oil & Gas and Power)
Gas Analysis, Detection, Monitoring
General Industrial Products
Industry 4.0 / IIoT
Non Destructive Testing / Metrology
Optics & Photonics
PPE, Safety & Security
Pumps, Valves & Flow control
Specialty Chemicals and Ingredients
Test & Measurement / Instruments
Transportation & Aerospace
Water/Wastewater & Environmental
View by Transaction Type
Filter Categories
All Transaction Types
Buyside
Sellside
Corporate divestiture
Cross border
Portfolio Add-on
Portfolio Exit
View by Location
Filter Categories
All Regions
North America
Europe
Asia and Australia
Africa
South America
